We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NEM:ASXNewmont Corporation Registered Shs Chess Depositary Interests Repr 1 Sh Analysis

Data as of 2026-05-19 - not real-time

A$153.43

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Newmont’s share price is trading comfortably above its 20‑day and 50‑day simple moving averages, confirming the bullish trend indicated by the trend_direction metric. The RSI sits near the mid‑range at around 45, suggesting modest upside momentum without immediate overbought pressure. While the MACD histogram remains negative, the signal line is only marginally above zero, pointing to a potential near‑term consolidation rather than a sharp reversal. A beta well below one underscores the stock’s defensive profile relative to the broader market, yet the 30‑day volatility is elevated, reflecting the inherent swing of commodity prices. The discounted cash‑flow model values the company at roughly double the current market price, delivering an upside potential of close to 28 % according to the upside_downside_pct figure. Analyst coverage is bullish, with a consensus “buy” and a median price target above the current level.
Fundamentally, Newmont posts robust profitability – operating margins exceed 60 % and return on equity is above 25 %, while cash generation remains strong, supporting a sustainable dividend at a low payout ratio. The company’s revenue growth of roughly 46 % and a solid balance sheet with ample cash relative to debt further reinforce its resilience. However, regulatory risk has surfaced in Ghana, where the firm must transition operations to local contractors by the end of 2026, and the diversified geographic footprint introduces medium‑to‑high country‑specific risk. The modest dividend yield under 1 % is offset by the low payout and strong cash flow, making the dividend sustainable. Taken together, the valuation appears undervalued, the growth‑value mix is balanced, and the risk profile is manageable, supporting a positive investment outlook.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above key moving averages supports momentum
  • Analyst consensus remains bullish with favorable price targets
  • Regulatory deadline in Ghana is not imminent

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF valuation indicates substantial upside
  • Strong cash flow and low payout ratio sustain dividend
  • Robust operating margins and ROE underpin earnings growth

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term gold demand and diversified asset base
  • Consistently high profitability and solid balance sheet
  • Undervalued relative to intrinsic value and attractive upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth45.80%
Profit Margin33.87%
P/E Ratio14.2
ROE25.83%
ROA14.89%
Debt/Equity15.76
P/B Ratio3.4
Op. Cash FlowA$12.1B
Free Cash FlowA$9.8B

Technical Analysis

TrendBullish
RSI45.1
SupportA$149.41
ResistanceA$167.73
MA 20A$157.25
MA 50A$156.79
MA 200A$144.53
MACDBearish
VolumeStable
Fear & Greed Index89.18

Valuation

Fair ValueA$327.72
Target PriceA$196.32
Upside/Downside27.95%
GradeUndervalued
TypeBlend
Dividend Yield0.95%

Risk Assessment

Beta0.73
Volatility43.79%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.